Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811).
Argiris A, Miao J, Cristea MC, Chen AM, Sands JM, Decker RH, Gettinger SN, Daly ME, Faller BA, Albain KS, Yanagihara RH, Garland LL, Byers LA, Wang D, Koczywas M, Redman MW, Kelly K, Gandara DR. Argiris A, et al. Among authors: koczywas m. Clin Lung Cancer. 2021 Jul;22(4):313-323.e1. doi: 10.1016/j.cllc.2021.02.009. Epub 2021 Feb 19. Clin Lung Cancer. 2021. PMID: 33745865 Free PMC article. Clinical Trial.
Carboplatin and Paclitaxel in combination with either vorinostat or placebo for first-line therapy of advanced non-small-cell lung cancer.
Ramalingam SS, Maitland ML, Frankel P, Argiris AE, Koczywas M, Gitlitz B, Thomas S, Espinoza-Delgado I, Vokes EE, Gandara DR, Belani CP. Ramalingam SS, et al. Among authors: koczywas m. J Clin Oncol. 2010 Jan 1;28(1):56-62. doi: 10.1200/JCO.2009.24.9094. Epub 2009 Nov 23. J Clin Oncol. 2010. PMID: 19933908 Free PMC article. Clinical Trial.
Phase II study of Cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (National Cancer Institute #7097).
Ramalingam SS, Belani CP, Mack PC, Vokes EE, Longmate J, Govindan R, Koczywas M, Ivy SP, Gandara DR. Ramalingam SS, et al. Among authors: koczywas m. J Thorac Oncol. 2010 Aug;5(8):1279-84. doi: 10.1097/JTO.0b013e3181e2fcb0. J Thorac Oncol. 2010. PMID: 20559150 Free PMC article. Clinical Trial.
Predictors of finding benefit after lung cancer diagnosis.
Thornton AA, Owen JE, Kernstine K, Koczywas M, Grannis F, Cristea M, Reckamp K, Stanton AL. Thornton AA, et al. Among authors: koczywas m. Psychooncology. 2012 Apr;21(4):365-73. doi: 10.1002/pon.1904. Epub 2011 Jan 20. Psychooncology. 2012. PMID: 21254308
Quality of life and barriers to symptom management in colon cancer.
Sun V, Borneman T, Koczywas M, Cristea M, Piper BF, Uman G, Ferrell B. Sun V, et al. Among authors: koczywas m. Eur J Oncol Nurs. 2012 Jul;16(3):276-80. doi: 10.1016/j.ejon.2011.06.011. Epub 2011 Jul 23. Eur J Oncol Nurs. 2012. PMID: 21783415 Free PMC article.
A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer.
Baggstrom MQ, Qi Y, Koczywas M, Argiris A, Johnson EA, Millward MJ, Murphy SC, Erlichman C, Rudin CM, Govindan R; Mayo Phase 2 Consortium; California Consortium. Baggstrom MQ, et al. Among authors: koczywas m. J Thorac Oncol. 2011 Oct;6(10):1757-60. doi: 10.1097/JTO.0b013e31822e2941. J Thorac Oncol. 2011. PMID: 21918390 Free PMC article. Clinical Trial.
103 results